v.231201
Showing details for project SYSMHC00079
| SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
| SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
| SYSMHC00079_DPrep1 |
4 |
Human |
|
|
HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401 |
| SYSMHC00079_DPrep2 |
4 |
Human |
|
|
HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401 |
| SYSMHC00079_DPrep3 |
4 |
Human |
|
|
HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401 |
| SYSMHC00079_DPrep4 |
16 |
Human |
|
|
HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401 |
| SYSMHC00079_DPrep5 |
16 |
Human |
|
|
HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401 |
| SYSMHC00079_DQrep1 |
19 |
Human |
|
|
HLA-DQA10505-DQB10301 |
| SYSMHC00079_DQrep2 |
6 |
Human |
|
|
HLA-DQA10505-DQB10301 |
| SYSMHC00079_DQrep3 |
4 |
Human |
|
|
HLA-DQA10505-DQB10301 |
| SYSMHC00079_DQrep4 |
4 |
Human |
|
|
HLA-DQA10505-DQB10301 |
| SYSMHC00079_DQrep5 |
6 |
Human |
|
|
HLA-DQA10505-DQB10301 |
| SYSMHC00079_DQrep6 |
16 |
Human |
|
|
HLA-DQA10505-DQB10301 |
| SYSMHC00079_DRrep1 |
4 |
Human |
|
|
DRB1_1201,DRB3_0202 |
| SYSMHC00079_DRrep2 |
8 |
Human |
|
|
DRB1_1201,DRB3_0202 |
| SYSMHC00079_DRrep3 |
4 |
Human |
|
|
DRB1_1201,DRB3_0202 |
| SYSMHC00079_DRrep4 |
16 |
Human |
|
|
DRB1_1201,DRB3_0202 |
| SYSMHC00079_DRrep5 |
15 |
Human |
|
|
DRB1_1201,DRB3_0202 |
| SYSMHC00079_DRrep6 |
15 |
Human |
|
|
DRB1_1201,DRB3_0202 |
| SYSMHC00079_DRrep7 |
31 |
Human |
|
|
DRB1_1201,DRB3_0202 |
Detailed view of sample SYSMHC00079_DRrep1
| ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue Type |
Cell Type |
Culture Conditions |
Disease State |
Comments |
MHCClass |
MHCAllele |
PubMed ID |
Peptide |
Isolation Method |
Antibody |
Mass Spectrometer |
LC System |
iRT Peptides |
Acquisition Mode |
Fragmentation Method |
Gradient |
Gradient Length |
Flow Rate |
Replicate Number |
| ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue_Type |
Cell_Type |
Culture_Conditions |
Disease_State |
Comments |
MHCClass |
MHCAllele |
PubMed_ID |
Peptide |
Isolation_Method |
Antibody |
Mass_Spectrometer |
LC_System |
iRT_Peptides |
Acquisition_Mode |
Fragmentation_Method |
Gradient |
Gradient_Length |
Flow_Rate |
Replicate_Number |
| SYSMHC00079 |
SYSMHC00079_DRrep1 |
DRrep1_A1112.wiff |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class II |
DRB1_1201,DRB3_0202 |
PXD025877 |
native |
Immunoaffinity |
LB3.1 |
Triple-TOF 5600 |
|
no |
DDA |
CID-QTOF |
|
90 |
300 nL/min |
1 |
| SYSMHC00079 |
SYSMHC00079_DRrep1 |
DRrep1_A13.wiff |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class II |
DRB1_1201,DRB3_0202 |
PXD025877 |
native |
Immunoaffinity |
LB3.1 |
Triple-TOF 5600 |
|
no |
DDA |
CID-QTOF |
|
90 |
300 nL/min |
2 |
| SYSMHC00079 |
SYSMHC00079_DRrep1 |
DRrep1_A579.wiff |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class II |
DRB1_1201,DRB3_0202 |
PXD025877 |
native |
Immunoaffinity |
LB3.1 |
Triple-TOF 5600 |
|
no |
DDA |
CID-QTOF |
|
90 |
300 nL/min |
3 |
| SYSMHC00079 |
SYSMHC00079_DRrep1 |
DRrep1_A6810.wiff |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class II |
DRB1_1201,DRB3_0202 |
PXD025877 |
native |
Immunoaffinity |
LB3.1 |
Triple-TOF 5600 |
|
no |
DDA |
CID-QTOF |
|
90 |
300 nL/min |
4 |